Independent predictors of 18 months mortality
| Characteristics | Clinical model | Clinical model + drug treatment at baseline | Clinical model + drug treatment at baseline + NYHA class | Clinical model + drug treatment at baseline + NYHA class + quality of life score |
|---|---|---|---|---|
| Values are odds ratios (95% confidence interval) except for ROC area. | ||||
| *Without oedema and lower systolic or diastolic blood pressure, AUC = 0.82. | ||||
| †Without oedema and lower systolic or diastolic blood pressure, AUC = 0.84. | ||||
| CI, confidence interval; MHFQ, Minnesota heart failure questionnaire; NYHA, New York Heart Association; ROC, receiver operating characteristic. | ||||
| Age | 1.00 (0.98 to 1.04) | 1.01 (0.97 to 1.04) | 1.00 (0.97 to 1.04) | 1.00 (0.97 to 1.04) |
| Male sex | 0.67 (0.31 to 1.43) | 1.52 (0.69 to 3.34) | 1.04 (0.44 to 2.47) | 1.27 (0.52 to 3.09) |
| History of diabetes | 2.35 (1.17 to 4.77) | 2.37 (1.15 to 4.85) | 2.53 (1.19 to 5.38) | 2.76 (1.26 to 6.07) |
| History of renal insufficiency | 4.02 (1.56 to 10.38) | 5.22 (1.88 to 14.45) | 4.14 (1.49 to 11.48) | 3.69 (1.28 to 10.63) |
| Ankle oedema | 2.82 (1.40 to 5.71) | 2.81 (1.36 to 5.82) | 1.99 (0.89 to 4.42) | 1.62 (0.72 to 3.65) |
| Weight | 0.96 (0.93 to 0.98) | 0.96 (0.94 to 0.99) | 0.96 (0.93 to 0.99) | 0.96 (0.93 to 0.99) |
| Lower systolic (<110) or diastolic (<70) blood pressure | 2.16 (1.09 to 4.25) | 2.10 (1.05 to 4.22) | 1.94 (0.93 to 4.04) | 1.81 (0.85 to 3.83) |
| Non-use of β blockers | 3.68 (1.73 to 7.84) | 3.40 (1.52 to 7.59) | 3.21 (1.43 to 7.23) | |
| NYHA class III or IV | 4.91 (2.33 to 10.34) | 4.18 (1.95 to 8.96) | ||
| MHFQ score >37 | 3.24 (1.38 to 7.62) | |||
| ROC area (95% CI) | 0.77 (0.69 to 0.84) | 0.80 (0.72 to 0.87) | 0.84 (0.77 to 0.90)* | 0.85 (0.79 to 0.92)† |